期刊文献+

粗根荨麻多糖对人脐血单核细胞源树突细胞表面分子表达的影响 被引量:3

Urtica macrorrhiza Hand-Mazz Polysaccharides Induce Cord Blood Monocytes into Mature Dendritic Cells( DCs)and Its Effect on Surface Molecules Expression of DCs
下载PDF
导出
摘要 研究粗根荨麻多糖在体外对人脐血单核细胞向树突细胞分化及成熟的作用。用淋巴细胞分离液分离脐血获得脐血单个核细胞,将获得的单核细胞分为3组,实验组:在含有粗根荨麻多糖(200 mg/L)的RPMI1640完全培养液中培养;阴性对照组:在无药物的RPMI1640完全培养液中培养;阳性对照组:在含有细胞因子(IL-4、GM-CSF、TNF-α)的RPMI1640完全培养液中培养;收集第10 d细胞用流式细胞术检测DCs成熟表型(CD1a、CD80、CD83、CD86、HLA-DR)。结果表明,与阴性对照组比较,实验组和阳性对照组CD80、CD83、CD86、HLADR、CD1a的表达明显增加。粗根荨麻多糖可诱导脐血单核细胞分化成熟的DCs。 To study the effect of Urtica macrorrhiza Hand-Mazz polysaccharides on in vitro induction of cord blood monocyte into dendritic cells(DCs) as well as its effect on the maturation and differentiation of DCs. Cord blood mononuclear cytes were separated by centrifuge in density gradient and were divided into three groups:cells cultured with U. macrorrhiza polysaccharides (200 mg/L) as experimental group, cells cultured with the cytokines of IL-4, GM-CSF and TNF-α as positive control group and cells cultured without either IL-4, GM-CSF, TNF-α or U. macrorrhiza polysaccharides as negative control group. The phenotype of 10 days cultures of DCs (CD1a, CDS0, CD83, CD86 and HLA-DR) were identified by flow cytometry. The results showed that compared with negative control group, cells of experimental group and positive group cultured for 10 days expressed significant increasing of the phenotypes of CD80, CD83, CD86, HLA-DR and CD1 a by flow cytometry. Hence, it was concluded that U. macrorrhiza polysaccharides, may induce the cord blood monocytes into mature DCs.
出处 《天然产物研究与开发》 CAS CSCD 北大核心 2016年第5期745-748,734,共5页 Natural Product Research and Development
基金 云南省应用基础研究-昆医联合专项(2014FB078)
关键词 树突细胞 粗根荨麻多糖 脐血单核细胞 细胞因子 dendritic cells Urtica macrorrhiza Hand-Mazz polysaccharide cord blood monocytes cytokin
  • 相关文献

参考文献8

二级参考文献127

  • 1张嫚丽,李作平,贾湘曼.麻叶荨麻化学成分研究[J].天然产物研究与开发,2005,17(2):175-176. 被引量:28
  • 2王梦月,李外,李晓波.荨麻水溶性化学成分研究[J].中国药学杂志,2005,40(24):1853-1855. 被引量:24
  • 3Imai Y,Yamakawa M. Dendritic cells in esophageal cancer and lymph node tissues[J]. In Vivo, 1993,7(3) :239-248.
  • 4Wesa AK,Storkus WJ. Killer dendritic cells:mechanisms of action and therapeutic implications for cancer[J]. Cell Death Differ, 200$ , 15 (1):51-57.
  • 5Reichardt VL,Brossart P. Dendritic cells in clinical trials for multiple myeloma[J]. Methods Mol Med,2005,5(23),127-136.
  • 6Shi M,Su L,Hao S, et al. Fusion hybrid of dendritic cells and engineered tumor cells expressing interleukin-12 induces type 1 immune responses against tumor[J]. Tumori. 2005,91(6):531-538.
  • 7Onaitis M,Kalady MF,Pruitt S,et al. Dendritic cell gene therapy[J]. Surg Oncol Clin N Am, 2002, 11 (3) : 645-660.
  • 8Son Y,Egawa S,Tatsumi T,et al.A noval dulk-culture method for generating mature dendritic cell from mouse bone marrow cells.J Immunol Methods 2002,262(1-2):145-57.
  • 9Aichun Liu,Takahashi M,Narita M,et al.Generation of function and mature dendritic cells from cord blood and bone marrow CD34 + cells by two-step culture combined with calcium ionophore treatment.J Immunol Methods 2002,261(1-2):49-63.
  • 10Berthier R,Martinon-Egoc,Laharie AM,et al.A two-step culture method starting with early growth factors permits enhanced production of functional dendritic cells from murine slpenocytes.J Immunol Methods 2000, 239(5):95-107.

共引文献31

同被引文献37

引证文献3

二级引证文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部